Small-Cap Quality Gems: High ROE, Low Debt, Under $10B
Small caps have been left for dead. Quality small caps trading at 10x earnings represent the best risk-reward in the equity market today.
Stoquity AI Committee1Theme Overview
The small-cap quality factor has been one of the strongest anomalies in academic finance. Novy-Marx (2013) demonstrated that profitability predicts returns as strongly as value. Small quality stocks receive less analyst coverage, creating information advantages.
2Why Now?
Small caps have underperformed large caps for 5+ years, creating a valuation gap. Quality small caps with strong fundamentals are trading at meaningful discounts to their historical P/E ranges.
3Screening Methodology
Screen for small-cap stocks ($2B-$10B market cap) scoring in the top decile on Stoquity's quality composite, combining ROE, margin stability, and balance sheet strength.
Factors used: QualityReturn on EquityProfitabilityLeverageEarnings Stability
4Top Picks (5 Stocks)
Thesis: Monopoly-like position in credit scoring with 90%+ market share. Software platform revenue growing 20%+ with 80%+ operating margins.
Risks: Regulatory scrutiny on credit scoring practices; potential open-source alternatives; concentrated revenue model.
Thesis: Dominant distributor of swimming pool supplies with 40%+ market share. Recurring maintenance revenue provides stability. Installed base of 6M+ pools grows annually.
Risks: Housing market sensitivity; weather dependency; new pool construction cyclicality.
Thesis: Asset-light trucking model with independent agents. Near-zero debt, 25%+ ROE, consistent free cash flow generation through freight cycles.
Risks: Freight recession compresses margins; agent retention risk; technology disruption from digital freight platforms.
Thesis: Market leader in protein reagents and diagnostics instruments. 65%+ gross margins with high switching costs. Essential supplier to pharmaceutical R&D.
Risks: Biotech funding cycles affect customer spending; acquisition integration risk; competition from larger life science companies.
Thesis: Environmental and infrastructure consulting leader. Beneficiary of federal infrastructure spending and PFAS remediation demand. High recurring revenue from government contracts.
Risks: Government budget sequestration risk; project execution risk; competition from larger engineering firms.
View compact comparison table
| Symbol | Name | Sector | Score | Market Cap |
|---|---|---|---|---|
| FICO | Fair Isaac Corporation | Technology | 91 | $9.5B |
| POOL | Pool Corporation | Consumer Discretionary | 86 | $8.2B |
| LSTR | Landstar System | Industrials | 84 | $6.1B |
| TECH | Bio-Techne | Life Sciences | 83 | $7.8B |
| TTEK | Tetra Tech | Industrials | 82 | $9.0B |
5Theme Risks
Small caps carry higher volatility and liquidity risk. Even quality small caps can suffer 30-40% drawdowns in broad market selloffs. Limited analyst coverage means less price discovery and wider bid-ask spreads.
The Russell 2000 trades at its widest discount to the S&P 500 in 25 years. Quality small caps — those with high ROE and low debt — historically outperform large caps by 2-3% annually.
Screen stocks yourself
Use the same 24-factor scoring model that powers Stoquity portfolios.
Try the AI Screener →